General Information of Drug Transporter (DT)
DT ID DTD0195 Transporter Info
Gene Name SLC25A33
Transporter Name Bone marrow stromal cell mitochondrial carrier protein
Gene ID
84275
UniProt ID
Q9BSK2
Post-Translational Modification of This DT
Overview of SLC25A33 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A33 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

80

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A33 Serine 80 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A33 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

112

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A33 Tyrosine 112 has the potential to affect its expression or activity.
References
1 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2 Motif-specific sampling of phosphoproteomes. J Proteome Res. 2008 May;7(5):2140-50.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.